These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4117048)

  • 1. Development of plasma derivatives for clinical use.
    Tullis JL
    Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiences in the development of plasma derivatives in Japan.
    Naito R
    Vox Sang; 1972; 23(1):35-7. PubMed ID: 4117047
    [No Abstract]   [Full Text] [Related]  

  • 3. New trends in plasma fractionation.
    Steinbuch M
    Haematologia (Budap); 1983; 16(1-4):39-51. PubMed ID: 6207083
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma fractionation in the United States. A review for clinicians.
    Ness PM; Pennington RM
    JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885
    [No Abstract]   [Full Text] [Related]  

  • 5. The development of plasma derivatives in Canada.
    McVicar GA
    Vox Sang; 1972; 23(1):33-4. PubMed ID: 4117046
    [No Abstract]   [Full Text] [Related]  

  • 6. Fractionation of plasma with polyethylene glycol.
    Polson A; Ruiz-Bravo C
    Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood products.
    Med Lett Drugs Ther; 1979 Nov; 21(23):93-6. PubMed ID: 502967
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma fractionation in blood transfusion service.
    Haskó F; Salamon M; Bartha K; Dobó P
    Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of plasma derivatives in Australia.
    Schiff P
    Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156
    [No Abstract]   [Full Text] [Related]  

  • 10. The development of plasma derivatives in Switzerland.
    Kistler P
    Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011
    [No Abstract]   [Full Text] [Related]  

  • 11. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

  • 12. Present state and perspectives of the farctionation of human plasma, serum and placenta.
    Richter P
    Ann Immunol Hung; 1973; 17():85-92. PubMed ID: 4142679
    [No Abstract]   [Full Text] [Related]  

  • 13. Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines.
    Cheraghali AM; Aboofazeli R
    Transfus Med; 2009 Dec; 19(6):363-8. PubMed ID: 19778319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notes on the production of plasma derivatives in France.
    Steinbuch M
    Vox Sang; 1972; 23(1):56-7. PubMed ID: 4117049
    [No Abstract]   [Full Text] [Related]  

  • 15. Notes on the development of plasma derivatives in the Netherlands.
    Krijnen HW
    Vox Sang; 1972; 23(1):32. PubMed ID: 5081012
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment with blood and blood plasma fractions].
    Weise W
    Dtsch Med J; 1967 Feb; 18(3):63-6. PubMed ID: 4174358
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-channel preparation of fresh blood an economic therapy with blood components.
    Schneider W; Glassner K; Fröhlich C; McCarty LJ
    Blut; 1974 Feb; 28(2):100-8. PubMed ID: 4130177
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfusion of specific plasma components.
    Tullis JL; Pennell RB
    Annu Rev Med; 1968; 19():233-46. PubMed ID: 4172726
    [No Abstract]   [Full Text] [Related]  

  • 19. Transmission of viral hepatitis, type B, by plasma derivatives.
    Barker LF; Hoofnagle JH
    Dev Biol Stand; 1974; 27():178-88. PubMed ID: 4142771
    [No Abstract]   [Full Text] [Related]  

  • 20. TRANSFUSION OF BLOOD FRACTIONS.
    SALSBURY AJ
    Practitioner; 1965 Aug; 195():193-200. PubMed ID: 14328859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.